Don’t forget 10:30am Meet at ASN Communities table @edgarvlermamd.bsky.social and Dr Roger Rodby 😎 #KidneyWk

I’ll just leave this here… and slowly walk away 😅 #NephJC #Medsky #NephSky

First things first — where the story starts! Time to unpack the 4-hit hypothesis of IgA nephropathy — understanding each step opens doors to new treatments. #NephJC

@kdigo.org is in #nephJc IgAN management is evolving with precision risk tools, new therapies, and a stronger focus on kidney protection. Check out VA by @roxnonna23.bsky.social Join tomorrow night discussion #nephsky #medsky

Join the @theisn.org @kdigo.org Small steps, big impact. What is the CKD burden today? 👉🏻 🆕 approach 4 CKD detection 👉🏻join now: t.co/CGHoqsn8kF #Nephsky #Medsky

The latest empadata dump: @nephroseeker.medsky.social writes up a #NephJC short on the meta analysis www.nephjc.com/news/2025/10...

Obi seems to deliver the answer ✨ …but leaves a few questions: 👉 Safety 👉 Post-biopsy tx 👉 💰 costs? #nephjc

Love this time of the year 💜 Getting ready for the next #NephJC ☕️ Can’t wait for the 2025 kit‼️ Don’t forget to make your donation 🙌 👉🏻 www.nephjc.com/news/2025/9/... #NephSky #MedSky

Unete al chat 🔗 #NephJC! 🫘

En el consumo de proteínas en la enfermedad renal, nada está concluido. Más que nuevas hipótesis, necesitamos mejores preguntas #NephJC

Ante un nivel de evidencia 2C, existen otras opciones individualizadas más considerarse razonables y menos 💰 #NephJC

Restricción proteica, cetoanálogos, probióticos… ¿Optimización nutricional o la nueva receta para la polifarmacia en la enfermedad renal? 💭 #NephJC

¿Qué dice la evidencia? 🔹 0.3 g/kg/día + cetoanálogos 🆚 🔹 0.8 g/kg/día, como recomienda @kdigo.org ¿Cuál estrategia realmente beneficia a los pacientes con #EnfermedadRenal ?💭 #NephJC

🎨 No olviden revisar la versión en español traducir por @dramiliflores.bsky.social #NephJC

Revisa el resumen visual y únete hoy a #NephJC 🫘

Hoy en #NephJC : ¿vale la pena restringir proteínas en la #enfermedadrenal? Ahora imagina vivir así todos los días 🫠

Check out the VA by @thekidneywhisperer.bsky.social for tonite's #NephJC discussion on chimerism 🦁🐐🐍 in transplantation. #NephSky #MedSky 9/30/25 at 9 pm only on Bluesky www.nephjc.com/news/2025/chimerism-kidney-trx

4/ Our #Skeetorial is based on a recent publication by Dr. Carl Waltherand VA by @husamjz.bsky.social : Kidney Function Trajectories with Mechanical Circulatory Support 🗞️ www.kireports.org/article/S246...

What would be the outcomes on this target population ? #NephJC #NephSky

Still 📊 76% start HD with a catheter 📉 <35% access pillars of CKD care 🌍 In unequal settings, gaps only widen. 🫘 #Kidneyhealthmatters #NephSky #MedSky #ThisIsISN

La tolerancia inmunológica es el verdadero santo grial del trasplante. ¿Estamos más cerca de alcanzarlo? #NephJC

Inmunosupresión: entre luces, sombras y realidades. #NephJc

¿The G.O.A.T of kidney trasplant vs the Bellerophon of immunosupression? Nephrons filtering drama 🫘 Tonight on #NephJC #NephSky #MedSky

Yes! Slide care of Paul Whelton at this year’s #Hypertension25 #nephjc

RAASi remain cornerstone therapies 🧩 Proven to slow CKD & cut CV risk ❤️ Still underused 🚫—mainly of hyperK⚡️ It’s time to use the RAASi toolkit! #NephSky #MedSky @theisn.org

Spooky vibes on MRAs early 👻 #nephJC

RDN and BP #NephJC

PREVENT and ⚠️ #NephJC

What about the normokalemic? #nephjC

Super practical for clinic flow. Are you using a checklist approach, or mostly triggered by red flags? #NephJC

Keeping it safe? #NephJC

Plenty to discuss on how we implement #nephjC

10 key takeaways from the new AHA/ACC 2025 Hypertension Guidelines 📈 #NephJC

When to choose an RCT? 👤 Individual randomization 👥 Cluster randomization 👉 Pick based on who receives the intervention & risk of contamination. #ThisIsISN @theisn.org

Some more #NephJC

Different stories, limit results on spiro & ESRD #NephJC

Contrast highlights … how co interventions matter #NephJC

Spiro CV promise in dialysis may be an illusion — or perhaps “too late” in the ESRD Evolution #nephjc

ACHIEVE table 1 Any oustanding details? Run-in data? Diversity? #NephJC

T0c: 💔 CV morbidity & mortality in ESRD is driven by: 🔹 Cardiac remodeling, ischemia and myocardial fibrosis All fueled by chronic pressure–volume overload + inadequate salt/water excretion → relative hyperaldosteronism 🧂 #NephJC www.imrpress.com/jou...